Illumina Hit With Antitrust Suit Over Alleged Patent Fraud
Illumina stifled competition with fraudulently obtained patents and "baseless" infringement litigation, a rival company alleged Monday in a suit filed in California federal court, accusing the gene-sequencing behemoth of maintaining U.S....To view the full article, register now.
Already a subscriber? Click here to view full article